Update on the Diagnosis and Management of Progressive Supranuclear Palsy

Abstract Progressive supranuclear palsy (PSP) is an adult-onset neurodegenerative disease clinically characterized by a variable combination of symmetrical parkinsonism, early postural instability and falls, vertical supranuclear ophthalmoparesis, and cognitive decline. PSP is a disorder of 4-repeat tau protein aggregation, belonging to the family of tauopathies. A broad phenotypic variability has been recognized, and specific clinical diagnostic criteria are available. Several ancillary tests are helpful for diagnosis; however, there are no diagnostic biomarkers, and definite diagnosis still requires histopathological confirmation. Symptomatic management of PSP patients is limited, but recent advances in the understanding of its pathophysiology might lead us to disease-modifying treatments. A multidisciplinary approach is essential in managing the symptom complexity of a progressive condition such as PSP.
Source: Current Geriatrics Reports - Category: Geriatrics Source Type: research